Search

The National University of Singapore is hiring a research assistant to study the microbiology of anaerobes and phages.

PHAVES #19 will be a seminar by Dr. Ameneh Khatami, who is a senior lecturer in Child and Adolescent Health for the University of Sydney, based at The Children’s Hospital at Westmead, where she also works as a paediatric infectious diseases

PHAVES #19 will be a seminar by Dr. Ameneh Khatami, who is a senior lecturer in Child and Adolescent Health for the University of Sydney, based at The Children’s Hospital at Westmead, where she also works as a paediatric infectious diseases

Apurva Virmani Johri (Vitalis Phage Therapy, India) and colleagues published a case report in Frontiers in Pharmacology on phage therapy for treatment of chronic bacterial prostatitis. Significant improvements in symptoms and re-testing of

Joshua Borin (University of California San Diego) and colleagues published a new paper in PNAS showing that coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance. For example, they

Clément Coclet and Simon Roux (DOE Joint Genome Institute) published a review in Current Opinion in Virology on major challenges of host prediction methods for uncultivated phages. They highlight different approaches, giving their distinct

Eleanor Townsend (University of Warwick) and colleagues published a new review in Frontiers in Cellular and Infection Microbiology on the origins and roles of phages in the human gut microbiome. They review phageome development in infancy a

Stephan Tetter (ETH Zurich) and colleagues published a report in Science on developing virus-like 'artificial nucleocapsid' carriers for diverse vaccine and delivery applications. They evolved a protein that forms multimeric, spherical cage

A UC San Diego-led project found that pre-trained phages demonstrated they could delay the onset of bacterial resistance. biology.ucsd.edu

In our PHAVES seminar series last month, Dr. Laura Damioli and Dr. Greg Canfield (University of Colorado Anschutz) shared their experience treating their first patient with phage therapy for a spinal hardware infection. Here's the recording

A post-doc position is available in the Parent Lab (Michigan State University) to work on mechanisms of phage attachment to enteric pathogens. Genetics, biochemistry, and computational approaches as well as single-particle cryo-EM will be c

The Roach lab at San Diego State University is recruiting a postdoc to work as part of a highly interactive multidisciplinary research team focused on deciphering how the mammalian immune system directly interacts with phages and the potent

## Evergreen is coming and we are all-in! Sign up here to be part of the longest running phage meeting. Phagebiotics Research Foundation and Phage Directory present the 24th biennial Evergreen International Phage Meeting August 2-5th 2021

Dear current & future members of ISVM (International Society for Viruses of Microorganisms) Please take 4 min to fill out this survey to keep your membership active or to join our society. Stay up-to-date with exciting events that await th

## Evergreen is coming and we are all-in! Sign up here to be part of the longest running phage meeting. Phagebiotics Research Foundation and Phage Directory present the 24th biennial Evergreen International Phage Meeting August 2-5th 2021

Dear current & future members of ISVM (International Society for Viruses of Microorganisms) Please take 4 min to fill out this survey to keep your membership active or to join our society. Stay up-to-date with exciting events that await th

This is Hala Ali, a postdoctoral researcher at Bacteriology Department, Animal Health Research Institute, Egypt. I am looking for sponsor lab to host me for 6 or 9 months as a postdoc scholar funded by Egypt. I am interested in developing n

Adaptive Phage Therapeutics will be collaborating with Oyster Point Pharma (Nasdaq: OYST) to develop therapies to target multiple opthalmic diseases using APT’s PhageBank™ technology.

Adaptive Phage Therapeutics dosed the first patient in their phase 1/2 study to evaluate their PhageBank™ technology as a treatment for UTIs.

Michael Tisza and Christopher Buck (National Cancer Institute, NIH) published a new paper in PNAS showing how a catalog of > 45,000 viruses associated with human bodies reveals hidden associations with chronic diseases. Specifically, they f